Related references
Note: Only part of the references are listed.Long-Acting Recombinant Human Interleukin-7, NT-17, Increases Cytotoxic CD8 T Cells and Enhances Survival in Mouse Glioma Models
Jian L. Campian et al.
CLINICAL CANCER RESEARCH (2022)
Glioblastoma mutations alter EGFR dimer structure to prevent ligand bias
Chun Hu et al.
NATURE (2022)
Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance
Tianqi Liu et al.
NEURO-ONCOLOGY (2022)
Checkpoint: Inspecting the barriers in glioblastoma immunotherapies
Isabelle Preddy et al.
SEMINARS IN CANCER BIOLOGY (2022)
Mitochondrial-nuclear epistasis underlying phenotypic variation in breast cancer pathology
Pierre R. Bushel et al.
SCIENTIFIC REPORTS (2022)
Ferroptosis in cancer and cancer immunotherapy
Lei Zhao et al.
CANCER COMMUNICATIONS (2022)
A Novel 16-Genes Signature Scoring System as Prognostic Model to Evaluate Survival Risk in Patients with Glioblastoma
Zunpeng Yu et al.
BIOMEDICINES (2022)
Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma
Ying Bi et al.
BMC CANCER (2022)
An absolute human stemness index associated with oncogenic dedifferentiation
Hailong Zheng et al.
BRIEFINGS IN BIOINFORMATICS (2021)
Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma
Juri Kiyokawa et al.
CLINICAL CANCER RESEARCH (2021)
Ferroptosis-related gene AKR1C1 predicts the prognosis of non-small cell lung cancer
Fangfang Huang et al.
CANCER CELL INTERNATIONAL (2021)
Ferroptosis: mechanisms, biology and role in disease
Xuejun Jiang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2021)
A Ferroptosis-Related Prognostic Risk Score Model to Predict Clinical Significance and Immunogenic Characteristics in Glioblastoma Multiforme
Dongdong Xiao et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2021)
Broadening horizons: the role of ferroptosis in cancer
Xin Chen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients
Zihao Wang et al.
BRIEFINGS IN BIOINFORMATICS (2021)
The Role of Plasmacytoid Dendritic Cells in Cancers
Binhui Zhou et al.
FRONTIERS IN IMMUNOLOGY (2021)
Cancer-associated MSC drive tumor immune exclusion and resistance to immunotherapy, which can be overcome by Hedgehog inhibition
Sandra Cascio et al.
SCIENCE ADVANCES (2021)
Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40
Fan Yang et al.
NATURE COMMUNICATIONS (2021)
The bioinformatics toolbox for circRNA discovery and analysis
Liang Chen et al.
BRIEFINGS IN BIOINFORMATICS (2021)
Active PLK1-driven metastasis is amplified by TGF-β signaling that forms a positive feedback loop in non-small cell lung cancer
Sol-Bi Shin et al.
ONCOGENE (2020)
Multi-dimensional omics characterization in glioblastoma identifies the purity-associated pattern and prognostic gene signatures
Yi Xiong et al.
CANCER CELL INTERNATIONAL (2020)
Energy-stress-mediated AMPK activation inhibits ferroptosis
Hyemin Lee et al.
NATURE CELL BIOLOGY (2020)
Pooled variable scaling for cluster analysis
Jakob Raymaekers et al.
BIOINFORMATICS (2020)
Lumefantrine, an antimalarial drug, reverses radiation and temozolomide resistance in glioblastoma
Yetirajam Rajesh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Myeloid-Derived Suppressor Cell Subsets Drive Glioblastoma Growth in a Sex-Specific Manner
Defne Bayik et al.
CANCER DISCOVERY (2020)
Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 shedding
Lawrence P. Andrews et al.
SCIENCE IMMUNOLOGY (2020)
CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma
Kyle B. Lupo et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
β-Catenin induces transcriptional expression of PD-L1 to promote glioblastoma immune evasion
Linyong Du et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Clinical and Biological Significances of a Ferroptosis-Related Gene Signature in Glioma
Shenghua Zhuo et al.
FRONTIERS IN ONCOLOGY (2020)
Memory CD8+ T cell responses to cancer
Jichang Han et al.
SEMINARS IN IMMUNOLOGY (2020)
Neutrophil-induced ferroptosis promotes tumor necrosis in glioblastoma progression
Patricia P. Yee et al.
NATURE COMMUNICATIONS (2020)
A Novel Ferroptosis-related Gene Signature for Overall Survival Prediction in Patients with Hepatocellular Carcinoma
Jie-ying Liang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
Extracellular Matrix Protein Tenascin C Increases Phagocytosis Mediated by CD47 Loss of Function in Glioblastoma
Ding Ma et al.
CANCER RESEARCH (2019)
CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy
Weimin Wang et al.
NATURE (2019)
To cluster, or not to cluster: An analysis of clusterability methods
Andreas Adolfsson et al.
PATTERN RECOGNITION (2019)
Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling
Jiao Wu et al.
NATURE (2019)
The Hippo Pathway Effector TAZ Regulates Ferroptosis in Renal Cell Carcinoma
Wen-Hsuan Yang et al.
CELL REPORTS (2019)
Recent Progress in Ferroptosis Inducers for Cancer Therapy
Chen Liang et al.
ADVANCED MATERIALS (2019)
Molecular determinants of interaction between glioblastoma CD133+cancer stem cells and extracellular matrix
I. S. Bryukhovetskiy et al.
ANNALS OF ONCOLOGY (2019)
Emerging Strategies of Cancer Therapy Based on Ferroptosis
Zheyu Shen et al.
ADVANCED MATERIALS (2018)
Epidermal Growth Factor Receptor Extracellular Domain Mutations in Glioblastoma Present Opportunities for Clinical Imaging and Therapeutic Development
Zev A. Binder et al.
CANCER CELL (2018)
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
Tathiane M. Malta et al.
CELL (2018)
Clinical prognostic value of the isocitrate dehydrogenase 1 single-nucleotide polymorphism rs11554137 in glioblastoma
Akshitkumar M. Mistry et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Copy number profiling across glioblastoma populations has implications for clinical trial design
Patrick J. Cimino et al.
NEURO-ONCOLOGY (2018)
Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas
Theo A. Knijnenburg et al.
CELL REPORTS (2018)
Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8+ T cell activation in the presence of adjuvant temozolomide
Serena Pellegatta et al.
ONCOIMMUNOLOGY (2018)
Mutational Landscape of Secondary Glioblastoma Guides MET-Targeted Trial in Brain Tumor
Huimin Hu et al.
CELL (2018)
Radiogenomics to characterize regional genetic heterogeneity in glioblastoma
Leland S. Hu et al.
NEURO-ONCOLOGY (2017)
The PhytoClust tool for metabolic gene clusters discovery in plant genomes
Nadine Topfer et al.
NUCLEIC ACIDS RESEARCH (2017)
Follicular Helper T Cells
Carola G. Vinuesa et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 34 (2016)
Disease progression in recurrent glioblastoma patients treated with the VEGFR inhibitor axitinib is associated with increased regulatory T cell numbers and T cell exhaustion
Stephanie Du Four et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Integrative genomic analysis by interoperation of bioinformatics tools in GenomeSpace
Kun Qu et al.
NATURE METHODS (2016)
Pharmacogenomic agreement between two cancer cell line data sets
Nicolas Stransky et al.
NATURE (2015)
Regulatory T cells are not a strong predictor of survival for patients with glioblastoma
Alissa A. Thomas et al.
NEURO-ONCOLOGY (2015)
The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone
Remco J. Molenaar et al.
NEURO-ONCOLOGY (2014)
Tumor-Infiltrating Lymphocytes in Glioblastoma Are Associated with Specific Genomic Alterations and Related to Transcriptional Class
W. Caleb Rutledge et al.
CLINICAL CANCER RESEARCH (2013)
The T genotype of the MGMT C>T (rs16906252) enhancer single-nucleotide polymorphism (SNP) is associated with promoter methylation and longer survival in glioblastoma patients
K. L. McDonald et al.
EUROPEAN JOURNAL OF CANCER (2013)
Differentiating cutaneous squamous cell carcinoma and pseudoepitheliomatous hyperplasia by multiplex qRT-PCR
Albert Su et al.
MODERN PATHOLOGY (2013)
The Cbln family of proteins interact with multiple signaling pathways
Peng Wei et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Overview of the Matrisome-An Inventory of Extracellular Matrix Constituents and Functions
Richard O. Hynes et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas
Sumihito Nobusawa et al.
CLINICAL CANCER RESEARCH (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1α in human glioma in vitro and in vivo
Harun M. Said et al.
RADIOTHERAPY AND ONCOLOGY (2007)
Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain
Jeffrey C. Lee et al.
PLOS MEDICINE (2006)
Genetic pathways to glioblastoma:: A population-based study
H Ohgaki et al.
CANCER RESEARCH (2004)
PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme
JS Smith et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Share Paper
